Cargando…
Therapeutic potential of a dual mTORC1/2 inhibitor for the prevention of posterior capsule opacification: An in vitro study
Mammalian target of rapamycin (mTOR) serves a central role in regulating cell growth and survival, and has been demonstrated to be involved in the pathological progression of posterior capsule opacification (PCO). In the present study, the potency of PP242, a novel dual inhibitor of mTOR complex 1/2...
Autores principales: | Feng, Hao, Yang, Zhibo, Bai, Xue, Yang, Meirong, Fang, Yuan, Zhang, Xiaonan, Guo, Qiqiang, Ning, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810205/ https://www.ncbi.nlm.nih.gov/pubmed/29344639 http://dx.doi.org/10.3892/ijmm.2018.3398 |
Ejemplares similares
-
CTGF Contributes to the Development of Posterior Capsule Opacification: an in vitro and in vivo study
por: Ma, Bo, et al.
Publicado: (2018) -
Risk factors for the occurrence of visual-threatening posterior capsule opacification
por: Chen, Hung-Chi, et al.
Publicado: (2019) -
Posterior Capsule Opacification: A Review of Experimental Studies
por: Konopińska, Joanna, et al.
Publicado: (2021) -
Further Enhancement of Intraocular Open-Capsule Devices for Prevention of Posterior Capsule Opacification
por: Slutzky, Lee, et al.
Publicado: (2018) -
The effect of capsule tension ring on posterior capsule opacification: A meta-analysis
por: Zhang, Kaikai, et al.
Publicado: (2021)